CAS: 1443211-72-0 - Eleclazine
![1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl]-](https://static.cymitquimica.com/products/IN/thumb/DA001JBG.jpg)
1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl]-
CAS:1443211-72-0
Fórmula:
C21H16F3N3O3
Pureza:
97%
Forma y color:
Solid
Peso molecular:
415.3652
Ref: IN-DA001JBG
| 5mg | 119,00 € | ||
| 25mg | 199,00 € | ||
| 100mg | 628,00 € | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 28 de Octubre de 2024
Eleclazine free base
CAS:1443211-72-0
Eleclazine (GS-6615) is a late sodium current inhibitor for treating LQT3 syndrome and arrhythmias, shortens …
Fórmula:
C21H16F3N3O3
Forma y color:
Solid
Peso molecular:
415.37
Ref: TM-T71945
| 5mg | 70,00 € | ||
| 10mg | 119,00 € | ||
| 25mg | 271,00 € | ||
| 50mg | 464,00 € |
Entrega estimada en Estados Unidos, el Lunes 4 de Noviembre de 2024
![4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one](https://static.cymitquimica.com/products/10/thumb/F547024.jpg)
4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one
CAS:1443211-72-0
Pureza:
95.0%
Peso molecular:
415.37200927734375
Ref: 10-F547024
| 1g | A consultar |
Entrega estimada en Estados Unidos, el Martes 5 de Noviembre de 2024
Eleclazine
Producto controladoCAS:1443211-72-0
Fórmula:
C21H16F3N3O3
Forma y color:
Neat
Peso molecular:
415.365
Ref: TR-E975168
| 50mg | 259,00 € | ||
| 250mg | 1.112,00 € | ||
| 500mg | 1.748,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
eleclazine
CAS:1443211-72-0
Eleclazine is a pharmaceutical drug that is used to treat a variety of diseases. It …
Fórmula:
C21H16F3N3O3
Pureza:
Min. 95%
Peso molecular:
415.37 g/mol
Ref: 3D-THC21172
| 1g | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
